| Literature DB >> 26346983 |
Ankur Kalra1, Daniel E Forman2, Sarah J Goodlin3.
Abstract
There has been a significant decline in cardiovascular morbidity and mortality amidst pervasive advances in care, including percutaneous revascularization, mechanical circulatory support, and transcatheter valvular therapies. While advancing therapies may add significant longevity, they also bring about new end-of-life decision-making challenges for patients and their families who also must weigh the advantages of reduced mortality to the possibility of longer lives consisting of high morbidity, frailty, pain, and poor quality of living. Advance care entails options of withholding or withdrawing therapies, and has become a familiar part of cardiovascular care for older patients in Western countries. However, as advanced cardiovascular practices extend to developing countries, the interrelated concept of advance care is rarely straight forward as it is affected by local cultural traditions and mores, and can lead to very different inferences and use. This paper discusses the concepts of advance care planning, surrogate decision-making, orders for resuscitation and futility in patients with cardiac disease with comparisons of West to East, focusing particularly on the United States versus India.Entities:
Keywords: Advance care planning; Advance directive; End-of-life; India; Surrogate decision-making
Year: 2015 PMID: 26346983 PMCID: PMC4554781 DOI: 10.11909/j.issn.1671-5411.2015.04.003
Source DB: PubMed Journal: J Geriatr Cardiol ISSN: 1671-5411 Impact factor: 3.327
Advance directives.
| Living will | A document that states specific medical interventions and treatments the person would or would not want in the event she/he loses capacity and under specific circumstances (often in the event of life-threatening, terminal, or severely debilitating illness). Living wills often use boilerplate language that requires interpretation in light of real-time medical facts. For example, it may be difficult to interpret what was meant by “terminal illness.” Similarly, when a person states not to ever be “placed on machines,” it is not clear if this includes a trial of critical care in the event of an acute illness. Patients' oral statements may also state their preferences for future health care, in the event of loss of decision-making capacity. |
| Health care proxy | Also called durable power of attorney for health care, it designates a surrogate decision-maker to speak on behalf of the patient, when she/he can no longer make medical decisions. Designated health care agents work with the medical team to incorporate the patient's preferences, values, and goals to make decisions in real time. Clinicians should encourage patients to discuss their preferences, goals, and values with their designated health care agent. |
Surrogate decision-making: best practices for communication between providers and surrogates.
| Designate a skilled communicator from the medical team and establish the relationship before difficult topics arise (if possible). |
| Ask about what has been important to the patient in the past and what is likely to be important to the patient in the future. |
| Counsel surrogates that their role is to decide based on what the patient would want. |
| Define broad goals for care based on the patient's values. |
| Avoid presenting a menu of treatment decisions to the surrogate; rather focus on the goals of care. |
| Make specific care recommendations to achieve the goals. |